pentoxifylline has been researched along with Leishmaniasis, American in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a tumor necrosis factor-α (TNF-α) inhibitor that also attenuates the immune response and decreases tissue inflammation." | 2.79 | Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. ( Brito, G; Carvalho, EM; Carvalho, LP; Celestino, D; Dourado, M; Machado, PR; Passos, S; Polari, L; Queiroz, A, 2014) |
| "Cutaneous leishmaniasis is a common parasitic disease in Iran, especially in Isfahan." | 2.72 | Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. ( Nilforoushzadeh, MA; Sadeghian, G, 2006) |
| "Pentoxifylline (PTX) is a methylxanthine derivative with a variety of anti-inflammatory effects." | 2.44 | Pentoxifylline: a drug with wide spectrum applications in dermatology. ( Zargari, O, 2008) |
| "American cutaneous leishmaniasis is characterized by single or multiple ulcerations." | 1.32 | American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. ( Báfica, A; Barral, A; Freitas, LA; Nascimento, EG; Oliveira, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinart, M | 1 |
| Rueda, JR | 1 |
| Romero, GA | 1 |
| Pinzón-Flórez, CE | 1 |
| Osorio-Arango, K | 1 |
| Silveira Maia-Elkhoury, AN | 1 |
| Reveiz, L | 1 |
| Elias, VM | 1 |
| Tweed, JA | 1 |
| Martins, SS | 1 |
| Barroso, DH | 1 |
| Rodrigues, BC | 1 |
| da Motta, JOC | 1 |
| Freire, GSM | 1 |
| Pereira, LIA | 1 |
| Kurisky, PS | 1 |
| Gomes, CM | 1 |
| Sampaio, RNR | 1 |
| Brito, G | 2 |
| Dourado, M | 2 |
| Guimarães, LH | 1 |
| Meireles, E | 1 |
| Schriefer, A | 1 |
| de Carvalho, EM | 1 |
| Machado, PRL | 1 |
| Polari, L | 1 |
| Celestino, D | 1 |
| Carvalho, LP | 1 |
| Queiroz, A | 1 |
| Carvalho, EM | 1 |
| Machado, PR | 1 |
| Passos, S | 1 |
| Santarem, AA | 1 |
| Greggianin, GF | 1 |
| Debastiani, RG | 1 |
| Ribeiro, JB | 1 |
| Polli, DA | 1 |
| Sampaio, RN | 1 |
| Zargari, O | 1 |
| Báfica, A | 1 |
| Oliveira, F | 1 |
| Freitas, LA | 1 |
| Nascimento, EG | 1 |
| Barral, A | 1 |
| Sadeghian, G | 1 |
| Nilforoushzadeh, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata: a Clinical and Dermoscopic Study.[NCT06087796] | Phase 1 | 60 participants (Anticipated) | Interventional | 2023-10-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentoxifylline and Leishmaniasis, American
| Article | Year |
|---|---|
Interventions for American cutaneous and mucocutaneous leishmaniasis.
Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; BCG Vaccine; Female; Humans; Hypert | 2020 |
Pentoxifylline: a drug with wide spectrum applications in dermatology.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Behcet Syndrome; C | 2008 |
4 trials available for pentoxifylline and Leishmaniasis, American
| Article | Year |
|---|---|
A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Pentoxifylline; Phosphorylcholine; Pilot Pro | 2021 |
Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Brazil; Double-Blind Method; Drug Therapy, Combin | 2017 |
Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline.
Topics: Adult; Antimony; Chemokine CCL3; Chemokine CXCL10; Chemokine CXCL9; Double-Blind Method; Drug Therap | 2014 |
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hem | 2006 |
2 other studies available for pentoxifylline and Leishmaniasis, American
| Article | Year |
|---|---|
Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Evaluation, Precli | 2014 |
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.
Topics: Administration, Oral; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Leishmaniasis | 2003 |